Man Group PLC Innoviva, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Man Group PLC holds 404,978 shares of INVA stock, worth $7.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

404,978

Previous 457,953 11.57%

Holding current value

$7.76 Million

Previous $7.51 Million 4.07%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $865,081 - $1.06 Million	-52,975 Reduced 11.57%	404,978 $7.82 Million
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $685,670 - $780,902	47,616 Added 11.6%	457,953 $7.51 Million
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $464,769 - $535,634	31,921 Added 8.44%	410,337 $6.25 Million
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $42,491 - $56,115	-3,449 Reduced 0.9%	378,416 $6.07 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $209,584 - $235,338	-16,943 Reduced 4.25%	381,865 $4.96 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $209,576 - $252,448	-18,400 Reduced 4.41%	398,808 $5.08 Million
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $474,909 - $601,936	-44,260 Reduced 9.59%	417,208 $4.69 Million
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $287,719 - $335,997	-24,383 Reduced 5.02%	461,468 $6.11 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $640,314 - $839,413	55,152 Added 12.81%	485,851 $5.64 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $1.92 Million - $2.66 Million	133,824 Added 45.08%	430,699 $6.36 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $635,037 - $835,575	41,263 Added 16.14%	296,875 $5.75 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $396,890 - $466,989	24,946 Added 10.81%	255,612 $4.41 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $33,969 - $44,841	2,601 Added 1.14%	230,666 $3.85 Million
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $54,490 - $66,435	-4,759 Reduced 2.04%	228,065 $3.06 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $7.94 Million - $9.24 Million	-718,220 Reduced 75.52%	232,824 $2.78 Million
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $7.45 Million - $9.96 Million	-798,145 Reduced 45.63%	951,044 $11.8 Million
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $5.52 Million - $7.74 Million	534,405 Added 43.99%	1,749,189 $18.3 Million
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $398,048 - $528,652	-34,643 Reduced 2.77%	1,214,784 $17 Million
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $615,419 - $1.16 Million	-75,884 Reduced 5.73%	1,249,427 $14.7 Million
Q4 2019 Feb 18, 2020	SELL	$10.28 - $14.38 $1.9 Million - $2.66 Million	-185,238 Reduced 12.26%	1,325,311 $18.8 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $6.16 Million - $8.93 Million	-613,423 Reduced 28.88%	1,510,549 $15.9 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $1.95 Million - $2.23 Million	148,941 Added 7.54%	2,123,972 $30.9 Million
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $4.6 Million - $6.74 Million	335,954 Added 20.5%	1,975,031 $27.7 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $6.48 Million - $8.47 Million	464,068 Added 39.49%	1,639,077 $28.6 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $2.25 Million - $2.59 Million	164,942 Added 16.33%	1,175,009 $17.9 Million
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $514,859 - $673,837	-38,308 Reduced 3.65%	1,010,067 $13.9 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $14.5 Million - $17.8 Million	1,048,375 New	1,048,375 $17.5 Million

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account